News
A new study is reporting a link between a particular class of drugs used to treat type 2 diabetes and decreased Alzheimer's disease biomarkers. Alzheimer’s experts are calling for clinical ...
However, one expert is "not convinced by this study that glitazones or gliptins do not cause heart failure," and another cautions that "we will need to compare this with other additional studies ...
Gliptins are drugs used for the treatment of people with type 2 diabetes mellitus who cannot sufficiently lower their high levels of blood glucose with dietary changes and exercise alone or do ...
More on HF Hospitalization With Gliptins in Type 2 Diabetes. Lisa Nainggolan. June 24, 2014. SAN FRANCISCO — A new post hoc analysis of the VIVIDD study with the dipeptidyl peptidase 4 ...
The German Institute for Quality and Efficiency in Health Care (IQWiG) analysed additional data on drugs from the group of gliptins. The drug manufacturers had subsequently submitted these data to ...
Gliptins and Pancreatitis Risk: Analysis from 3 Large Trials. September 27, 2016 (HealthDay News) — Gliptin treatment is associated with increased acute pancreatitis risk, according to ...
South Korean researchers have suggested that certain diabetes drugs may help reduce Alzheimer’s risk in people with or without diabetes. TheHealthSite.com ...
Gliptins have been under a cloud for some years now, suspected of causing heart failures, and Merck, the company that owns sitagliptin, has subjected itself to a trial that other gliptins from its ...
Gliptins, widely used in the effective treatment of type 2 diabetes to safely regulate blood glucose levels, have also been found to provide neurological protection in Parkinson’s. In mouse studies, ...
Gliptins do not have any impact on the risk of major cardiovascular events compared with placebo, say researchers. In results described as ‘disappointing’, two large, placebo-controlled trials found ...
But patients taking gliptins and metformin lost more weight compared with adding sulfonylurea or glitazones, with differences of -1.92 and -2.96 respectively. In most trials comparing gliptins with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results